SNDA trades 50.7% below Wall Street's consensus target of $49.40.
Last 12 months price action with 12-month analyst target path
The base valuation assumes SNDA achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 6 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, Sonida Senior Living, Inc. (SNDA) has a Wall Street consensus price target of $49.40, based on estimates from 6 covering analysts. With the stock currently trading at $32.78, this represents a potential upside of +50.7%. The company has a market capitalization of $1.55B.
Analyst price targets range from a low of $43.00 to a high of $65.00, representing a 45% spread in expectations. The median target of $47.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 4 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, SNDA trades at a trailing P/E of -12.0x. Analysts expect EPS to grow +46.8% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 ENSGThe Ensign Group, Inc. | $10.6B | $181.08 | $223.25 | +23.3% | Buy | 22.7x | 13 |
 BKDBrookdale Senior Living Inc. | $2.2B | $9.01 | $19.50 | +116.4% | Buy | 300.3x | 12 |
 SGRYSurgery Partners, Inc. | $3.0B | $23.20 | $23.50 | +1.3% | Buy | 65.4x | 23 |
 CTRECareTrust REIT, Inc. | $9.0B | $38.21 | $43.88 | +14.8% | Buy | 24.6x | 19 |
 SHCSotera Health Company | $4.6B | $16.01 | $21.33 | +33.2% | Buy | 16.3x | 12 |
 NHCNational HealthCare Corporation | $3.3B | $208.85 | — | — | — | 26.2x | — |
 ADUSAddus HomeCare Corporation | $2.3B | $124.31 | $128.75 | +3.6% | Buy | 17.6x | 18 |
 WELLWelltower Inc. | $176.5B | $245.01 | $261.17 | +6.6% | Buy | 86.7x | 37 |
 VTRVentas, Inc. | $43.1B | $88.75 | $99.08 | +11.6% | Buy | 155.0x | 32 |
 OHIOmega Healthcare Investors, Inc. | $14.4B | $48.19 | $49.43 | +2.6% | Hold | 18.2x | 29 |
Quick answers to the most common questions about buying SNDA stock.
The consensus Wall Street price target for SNDA is $49.4, representing 50.7% upside from the current price of $32.78. With 6 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
SNDA has a consensus rating of "Buy" based on 6 Wall Street analysts. The rating breakdown is predominantly bullish, with 4 Buy/Strong Buy ratings. The consensus 12-month price target of $49.4 implies 50.7% upside from current levels.
SNDA's current price is $32.78 with a consensus target of $49.4 (50.7% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $65 for SNDA, while the most conservative target is $43. The consensus of $49.4 represents the median expectation. These targets typically reflect 12-month expectations.
SNDA is moderately covered, with 6 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 1 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month SNDA stock forecast based on 6 Wall Street analysts shows a consensus price target of $49.4, with estimates ranging from $43 (bear case) to $65 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on SNDA, with a "Buy" consensus rating and $49.4 price target (50.7% upside). 4 of 6 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
SNDA analyst price targets range from $43 to $65, a 45% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $49.4 consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.